ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NCEL vs OPTH // DIVIDEND YIELD & FCF PAYOUT SAFETY

NewcelX Ltd. (NASDAQ) VS. Optimi Health Corp. (NASDAQ) • 15-METRIC TALLY: NCEL 2 — OPTH 0
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NCEL VS. OPTH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NCEL OPTH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -17.84% — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 — — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 42.3 18.3 +23.95 NCEL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $15.5M $14.9M $662.1K NCEL /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NCEL REV OPTH REV NCEL GROSS % OPTH GROSS % NCEL FCF OPTH FCF
FY 2025 $0 — — — -$2.8M —
FY 2024 $0 — — — -$1.1M —
FY 2023 $0 — — — -$3.4M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NCEL // BETA —
OPTH // BETA —